Shillong Herald

Cluster Headache (CH) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

 Breaking News
  • No posts were found

Cluster Headache (CH) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

June 02
21:53 2021
Cluster Headache (CH) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

DelveInsight Business Research LLP
DelveInsight’s ‘Cluster Headache Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of and historical and forecasted epidemiology as well as the market trends of Cluster Headache in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

DelveInsight has launched a new report on “Cluster Headache (CH)-Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Cluster Headache (CH)–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Cluster Headache (CH), historical and forecasted epidemiology as well as the Cluster Headache (CH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. According to the organization, cluster headache is comparatively rare and it affects fewer than one in 1,000 adults which affects six men to each woman (“Headache Disorders,” n.d.)

  2. According to the research study, the pooled data for cluster headache showed that a lifetime prevalence of 124 per 100,000 and a 1-year prevalence of 53 per 100,000 (Fischera, Marziniak, Gralow, & Evers, 2008).

  3. According to the research study, the overall male to female ratio is 4.3, but it is much higher for chronic cluster headache than for the episodic form (15 and 3.8, respectively) (“Cluster Headache – American Family Physician,” n.d.).

  4. According to the research study, there are approximately 120,000 patients affected by cluster headache in Germany (Gaul, Diener, & Müller, 2011).

  5. The prevalence of cluster headache on the basis of population-based samples is reported to be 7–119/100, 000 (Gaul et al., 2011).

Key benefits of the report:

1.The Cluster Headache (CH) market report covers a descriptive overview and comprehensive insight of the Cluster Headache (CH) epidemiology and Cluster Headache (CH) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2.The Cluster Headache (CH) market report provides insights into the current and emerging therapies.

3.Cluster Headache (CH) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4.The Cluster Headache (CH) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Cluster Headache (CH) market.

Request for sample pages: https://www.delveinsight.com/sample-request/cluster-headache-market

Cluster Headache (CH): Overview

Cluster Headache is a major headache and is very common in a group of head problems called trigeminal autonomic cephalalgias. The term cluster headache comes from the fact that the attack occurred in groups, or “clusters.” During the group cycle severe headaches also occur between 1─8 times a day. Cluster cycles can last for weeks or months and are usually terminated during periods of remission, or periods of headaches, which usually last for months or years.

The key players involved in the Cluster Headache (CH) market:

  1. Eli Lilly and Company

  2. Zosano Pharma

  3. MindMed

The launch of the emerging therapies is expected to significantly impact the  Cluster Headache (CH) treatment scenario in the upcoming years:-

Drug covered

  1. Emgality (galcanezumab-gnlm)

  2. C213 Microneedle System

  3. LSD:  Mind Medicine 

Request a free sample report @https://www.delveinsight.com/sample-request/cluster-headache-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Cluster Headache (CH) Patient Share (%) Overview at a Glance

5. Cluster Headache (CH) Market Overview at a Glance

6. Cluster Headache (CH) Disease Background and Overview

7. Cluster Headache (CH) Epidemiology and Patient Population

8. Country-Specific Patient Population of Cluster Headache (CH) 

9. Cluster Headache (CH) Current Treatment and Medical Practices

10. Unmet Needs

11. Cluster Headache (CH) Emerging Therapies

12. Cluster Headache (CH) Market Outlook

13. Country-Wise Cluster Headache (CH) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Cluster Headache (CH) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Cluster Headache-Pipeline Insights, 2021

“Cluster Headache-Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Cluster Headache market. A detailed picture of the Cluster Headache pipeline landscape is provided, which includes the disease overview and Cluster Headache treatment guidelines.

Cluster Headache-Epidemiology Forecast to 2030

DelveInsight’s ‘Cluster Headache-Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Cluster Headache {;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles